Literature DB >> 10700699

Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride.

A M Sawka1, V Burgart, D Zimmerman.   

Abstract

A 17-year-old boy with type 1 diabetes mellitus developed new loss of hypoglycemia awareness while being treated with fluoxetine hydrochloride for depression. Hypoglycemia unawareness resolved after this medication was discontinued.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10700699     DOI： 10.1067/mpd.2000.103851

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  7 in total

1.  Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells.

Authors:  Joana Almaça; Judith Molina; Danusa Menegaz; Alexey N Pronin; Alejandro Tamayo; Vladlen Slepak; Per-Olof Berggren; Alejandro Caicedo
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

Review 2.  Psychosocial aspects of diabetes with an emphasis on depression.

Authors:  Michael D Harris
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

3.  Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes.

Authors:  Betina Biagetti; Rosa Corcoy
Journal:  World J Clin Cases       Date:  2013-08-16       Impact factor: 1.337

4.  Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes.

Authors:  Julia K Panzer; Alejandro Caicedo
Journal:  Diabetes       Date:  2021-12       Impact factor: 9.461

5.  Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy.

Authors:  Dinesh Giri; Victoria Price; Zoe Yung; Mohammed Didi; Senthil Senniappan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

6.  Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

7.  Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Sheila Dawling; Stephen N Davis
Journal:  Diabetes       Date:  2008-06-20       Impact factor: 9.461
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.